SB-497115-GR
≥99.7%
- Product Code: 56875
CAS:
496775-62-3
| Molecular Weight: | 564.63 g./mol | Molecular Formula: | C₂₉H₃₆N₆O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
SB-497115-GR is primarily utilized in the field of pharmaceutical research, particularly in the study of thrombopoietin receptor agonists. It plays a crucial role in the development of therapies aimed at treating conditions related to low platelet counts, such as thrombocytopenia. Researchers employ this compound to investigate its efficacy in stimulating platelet production, which is essential for patients undergoing chemotherapy or those with immune thrombocytopenic purpura (ITP). Additionally, SB-497115-GR is used in preclinical studies to understand its pharmacokinetics and pharmacodynamics, helping to optimize dosage and minimize potential side effects in future therapeutic applications. Its contribution to advancing treatments for blood disorders underscores its significance in medical research.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Purple to brown Powder |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | £60.66 |
+
-
|
| 0.250 | 10-20 days | £178.52 |
+
-
|
| 1.000 | 10-20 days | £448.83 |
+
-
|
| 5.000 | 10-20 days | £1,249.00 |
+
-
|
SB-497115-GR
SB-497115-GR is primarily utilized in the field of pharmaceutical research, particularly in the study of thrombopoietin receptor agonists. It plays a crucial role in the development of therapies aimed at treating conditions related to low platelet counts, such as thrombocytopenia. Researchers employ this compound to investigate its efficacy in stimulating platelet production, which is essential for patients undergoing chemotherapy or those with immune thrombocytopenic purpura (ITP). Additionally, SB-497115-GR is used in preclinical studies to understand its pharmacokinetics and pharmacodynamics, helping to optimize dosage and minimize potential side effects in future therapeutic applications. Its contribution to advancing treatments for blood disorders underscores its significance in medical research.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :